(e)
details of the actual or potential shortage of the medicinal product, such as actual or estimated start and end dates and suspected or known cause;
← art_9__para_3__point_d__text_1 · All articles · art_9__para_3__point_e__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.